+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intracoronary delivery of an adenovirus encoding fibroblast growth factor-4 in myocardial ischemia: effect of serum antibodies and previous exposure to adenovirus



Intracoronary delivery of an adenovirus encoding fibroblast growth factor-4 in myocardial ischemia: effect of serum antibodies and previous exposure to adenovirus



Human Gene Therapy 17(2): 230-238



The presence of anti-adenoviral serotype 5 (Ad5) antibodies may limit the efficacy of Ad5-mediated gene transfer. We therefore tested the hypothesis that intracoronary delivery of an adenovirus encoding human fibroblast growth factor type 4 (Ad5.FGF4) would improve regional myocardial function in an animal model of ischemia when high antibody levels preexist or after a prior intracoronary dose of Ad5. High anti-Ad5 antibody levels were generated in pigs by subcutaneous immunization with an adenovirus encoding LacZ (Ad5.lacZ). Neutralizing antibody levels increased 648-fold (range, 82- to 2108-fold) above preimmunization levels, and persisted for the duration of the study. Myocardial function during pacing-induced ischemia was improved in the ischemic region (p<0.001) at both 2 and 4 weeks after Ad5.FGF4 administration despite the presence of preexisting antibodies to Ad5. In a second set of experiments, the efficacy of a second intracoronary administration of Ad5 was determined by exposing the animals first to an intracoronary dose of Ad5.lacZ, followed 7 weeks later by the therapeutic dose of Ad5.FGF4. After delivery of Ad5.lacZ, anti-Ad5 antibody levels increased 8-fold (range, 1- to 18-fold), but this prior exposure to Ad5 did not prevent the therapeutic effects after subsequent intracoronary dosing with Ad5.FGF4 (p<0.001). In the porcine Ameroid constrictor model of myocardial ischemia the presence of anti-Ad5 antibodies or prior intracoronary dosing with adenovirus does not prevent the ability of Ad5.FGF4, delivered by intracoronary injection, from normalizing regional myocardial function.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012231297

Download citation: RISBibTeXText

PMID: 16454656

DOI: 10.1089/hum.2006.17.230


Related references

Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical data. Human Gene Therapy 15(6): 574-587, 2004

Intracoronary delivery of adenovirus encoding FGF4 increases regional wall thickness following myocardial infarction. FASEB Journal 16(4): A424, 2002

Reduced myocardial ischemia after recombinant adenovirus mediated in-vivo fibroblast growth factor-5 gene transfer. Journal of Investigative Medicine 43(Suppl. 2): 278A, 1995

Effect of intracoronary adenovirus vector encoding hepatocyte growth factor gene on hematopoietic stem cells mobilization in patients with extensive coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi 35(6): 504-508, 2007

Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation. Liver International 29(7): 1022-1030, 2009

Ocular neovascularization after adenovirus-mediated delivery of basic fibroblast growth factor. IOVS 39(4): S1117, 1998

Increased Left Ventricular Function after Intracoronary Gene Delivery of an Adenovirus Encoding Adenylyl Cyclase VI in Mice. FASEB Journal 18(4-5): Abst 823 2, 2004

Adenovirus-mediated gene transfer of fibroblast growth factor-2 increases BrdU-positive cells after forebrain ischemia in gerbils. Stroke 34(6): 1519-1525, 2003

Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity. Circulation 102(19): 2396-2401, 2000

Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice. American Journal of Physiology. Heart and Circulatory Physiology 287(1): H172-H177, 2004

Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Human Gene Therapy 10(8): 1331-1348, 1999

Global myocardial overexpression of beta2-adrenergic receptors via intracoronary adenovirus delivery enhances in vivo contractility. Circulation 98(17 Suppl. ): I737, 1998

Treatment of chronical myocardial ischemia by adenovirus-mediated hepatocyte growth factor gene transfer in minipigs. Science in China. Series C Life Sciences 51(6): 537-543, 2008

Adenovirus-mediated gene transfer of acidic fibroblast growth factor reduces the risk region in a rabbit model of myocardial infarction. Circulation 94(8 Suppl. ): I590-I591, 1996

Arteriogenic gene therapy in patients with unreconstructable critical limb ischemia: a randomized, placebo-controlled clinical trial of adenovirus 5-delivered fibroblast growth factor-4. Human Gene Therapy 16(10): 1202-1211, 2005